Menu
GeneBe

EYA2

EYA transcriptional coactivator and phosphatase 2, the group of EYA transcriptional coactivator and phosphatases|MicroRNA protein coding host genes

Basic information

Region (hg38): 20:46894623-47188844

Links

ENSG00000064655NCBI:2139OMIM:601654HGNC:3520Uniprot:O00167AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the EYA2 gene.

  • Inborn genetic diseases (24 variants)
  • not provided (3 variants)
  • Hereditary breast ovarian cancer syndrome (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the EYA2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
24
clinvar
2
clinvar
26
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 24 1 2

Variants in EYA2

This is a list of pathogenic ClinVar variants found in the EYA2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-46990081-G-A not specified Uncertain significance (Jun 29, 2023)2608272
20-46990108-G-A not specified Uncertain significance (Dec 08, 2023)3091317
20-47001440-C-T not specified Uncertain significance (Apr 22, 2022)2398736
20-47004952-C-A not specified Uncertain significance (Dec 06, 2022)2333685
20-47005009-A-G not specified Uncertain significance (Apr 07, 2022)2217031
20-47005048-C-T not specified Uncertain significance (Apr 05, 2023)2520274
20-47005063-G-A Benign (Apr 16, 2018)781566
20-47072204-A-C not specified Uncertain significance (Oct 10, 2023)3091310
20-47072244-G-A not specified Uncertain significance (Jun 23, 2023)2605869
20-47074198-C-T not specified Uncertain significance (Aug 30, 2022)2210591
20-47074209-G-C not specified Uncertain significance (Feb 27, 2023)2489204
20-47074211-C-T Likely benign (Jul 01, 2022)2652372
20-47074225-C-T not specified Uncertain significance (Dec 22, 2023)3091311
20-47074258-C-T not specified Uncertain significance (May 16, 2022)2219730
20-47074281-G-A not specified Uncertain significance (Jan 05, 2022)2207466
20-47074305-G-A not specified Uncertain significance (Sep 22, 2023)3091313
20-47089289-A-G Benign (Apr 16, 2018)782065
20-47089302-A-G not specified Uncertain significance (Feb 05, 2024)3091314
20-47089328-G-T Hereditary breast ovarian cancer syndrome • not specified Uncertain significance (Aug 12, 2021)981881
20-47089367-G-A not specified Uncertain significance (Mar 03, 2022)2410079
20-47089370-A-G not specified Uncertain significance (Jan 04, 2024)3091315
20-47097094-G-A not specified Uncertain significance (Oct 06, 2021)2367439
20-47143066-C-T not specified Uncertain significance (Jan 03, 2022)2268743
20-47143074-G-A not specified Uncertain significance (Nov 03, 2022)2322308
20-47143080-A-G not specified Uncertain significance (Jan 30, 2024)3091316

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
EYA2protein_codingprotein_codingENST00000327619 15294230
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.09800.9021257330141257470.0000557
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.202723340.8150.00002053482
Missense in Polyphen92152.90.601711601
Synonymous0.6221321410.9330.000009871058
Loss of Function3.82830.90.2590.00000149341

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002720.000272
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.000.00
European (Non-Finnish)0.00003530.0000352
Middle Eastern0.0001630.000163
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Functions both as protein phosphatase and as transcriptional coactivator for SIX1, and probably also for SIX2, SIX4 and SIX5 (PubMed:12500905, PubMed:23435380). Tyrosine phosphatase that dephosphorylates 'Tyr-142' of histone H2AX (H2AXY142ph) and promotes efficient DNA repair via the recruitment of DNA repair complexes containing MDC1. 'Tyr-142' phosphorylation of histone H2AX plays a central role in DNA repair and acts as a mark that distinguishes between apoptotic and repair responses to genotoxic stress (PubMed:19351884). Its function as histone phosphatase may contribute to its function in transcription regulation during organogenesis. Plays an important role in hypaxial muscle development together with SIX1 and DACH2; in this it is functionally redundant with EYA1 (PubMed:12500905). {ECO:0000269|PubMed:12500905, ECO:0000269|PubMed:19351884, ECO:0000269|PubMed:21706047, ECO:0000269|PubMed:23435380}.;
Pathway
DNA Repair;DNA Double-Strand Break Repair;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response (Consensus)

Recessive Scores

pRec
0.149

Intolerance Scores

loftool
0.0996
rvis_EVS
0.09
rvis_percentile_EVS
60.65

Haploinsufficiency Scores

pHI
0.812
hipred
Y
hipred_score
0.663
ghis
0.457

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.924

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Eya2
Phenotype

Gene ontology

Biological process
DNA repair;mesodermal cell fate specification;striated muscle tissue development;histone dephosphorylation;peptidyl-tyrosine dephosphorylation;positive regulation of DNA repair;anatomical structure development;extrinsic apoptotic signaling pathway in absence of ligand;mitochondrial outer membrane permeabilization;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
Cellular component
nucleus;nucleoplasm;mitochondrion;cytosol
Molecular function
magnesium ion binding;protein tyrosine phosphatase activity;protein binding;transcription factor binding